In silico Analysis of Interactions between HLA-A*31:01 and carbamazepine-related Compounds
- 1 June 2016
- journal article
- Published by Chem-Bio Informatics Society in Chem-Bio Informatics Journal
- Vol. 16, 5-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune ReceptorsInternational Archives of Allergy and Immunology, 2015
- HLA Restriction of Carbamazepine-Specific T-Cell Clones from an HLA-A*31:01-Positive Hypersensitive PatientChemical Research in Toxicology, 2014
- HLA-Modeler: Automated Homology Modeling of Human Leukocyte AntigensInternational Journal of Medicinal Chemistry, 2013
- Association of Carbamazepine Major Metabolism and Transport Pathway Gene Polymorphisms and Pharmacokinetics in Patients with EpilepsyPharmacogenomics, 2012
- Immune self-reactivity triggered by drug-modified HLA-peptide repertoireNature, 2012
- PharmGKB summaryPharmacogenetics and Genomics, 2011
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese populationHuman Molecular Genetics, 2010
- Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-DihydroxycarbamazepineDrug Metabolism and Disposition, 2008
- Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjectsEuropean Journal of Clinical Pharmacology, 2005
- 9-Hydroxymethyl-10-carbamoylacridan in human serum is one of the major metabolites of carbamazepine.Biological and Pharmaceutical Bulletin, 1995